Zentalis Pharmaceuticals, Inc.

SEC 4 · Filed

0001838041-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 8, 2026

Grant, award or other acquisition by Bruns Ingmar

Security
Stock Option (Right to Buy)
Code
A
Shares
365,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-01-08",
  "direction": "A",
  "exercise_price": "2.84",
  "expiration": "2036-01-07",
  "footnotes": {
    "F1": "The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person\u0027s continued service with the Issuer."
  },
  "owners": [
    {
      "cik": "0001838041",
      "name": "Bruns Ingmar",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "365000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "365000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "365000"
}